Targeting Wnt signaling at the neuroimmune interface for dopaminergic neuroprotection/repair in Parkinsons disease

During the past three decades, the Wingless-type MMTV integration site (Wnt) signaling cascade has emerged as an essential system regulating multiple processes in developing and adult brain. Accumulating evidence points to a dysregulation of Wnt signaling in major neurodegenerative pathologies including Parkinsons disease (PD), a common neurodegenerative disorder characterized by the progressive loss of midbrain dopaminergic (mDA) neurons and deregulated activation of astrocytes and microglia. This review highlights the emerging link between Wnt signaling and key inflammatory pathways during mDA neuron damage/repair in PD progression. In particular, we summarize recent evidence documenting that aging and neurotoxicant exposure strongly antagonize Wnt/-catenin signaling in mDA neurons and subventricular zone (SVZ) neuroprogenitors via astrocytemicroglial interactions. Dysregulation of the crosstalk between Wnt/-catenin signaling and anti-oxidant/anti-inflammatory pathways delineate novel mechanisms driving the decline of SVZ plasticity with age and the limited nigrostriatal dopaminergic self-repair in PD. These findings hold a promise in developing therapies that target Wnt/-catenin signaling to enhance endogenous restoration and neuronal outcome in age-dependent diseases, such as PD.